TBIO

Oncolytic viruses namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products for the prevention and treatment of cancer and infectious diseases, namely, biochemicals in the form of monoclonal antibodies for the treatment of cancer and chronic viral infections, biochemicals in the form of monoclonal antibodies for research use, protein and peptides for the treatment of cancer and chronic viral infections, pharmaceuticals and vaccines for human and veterinary use for the treatment of cancer and chronic viral infections

Research and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors, pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases and pharmaceutical and vaccine products in the field of cancer and infectious disease